CHASPIERRE HOLDING
ActiveSummary
CHASPIERRE HOLDING has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €44k and a net result of €35k. Its solvency ranks better than 15% of 10359 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.2% (low).
Checked score
Score 2025
50
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability45
Solvency29
Growth-
Track record67
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2k at 30 days acceptable
Liquidity short (current ratio 0.23; short-term debt: 9.9% and cash: 2.2% of total assets), and 96.1% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
3.9%
Return on assets
3.1%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 10359 sector peers (2025).
NBB · sector comparisonPosition among 10359 sector peers
Solvency
better than 15%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filingDeviation from the deadline
2025
31 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2025, abbreviated schema
Equity
€44k
Total assets
€1.13M
Net result
€35k
Working capital
€-86k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Balance-sheet composition
Assets €1.13M
Fixed assets
€1.10M
Current assets
€25k
Equity and liabilities €1.13M
Equity
€44k
Debt
€1.08M
Debt finances 96.1% of the balance-sheet total.
Key figures and ratios
Current ratio
0.23
Debt to equity
24.68
ROE
79.1%
ROA
3.1%
Debt ≤ 1 year
€111k
Debt > 1 year
€970k
Income taxes
€10k
Filed annual accounts As filed with the NBB · 2025 · 35 lines
Balance sheet
Code2025
Assets
Total assets20/58€1.13M
Fixed assets21/28€1.10M
Financial fixed assets28€1.10M
Current assets29/58€25k
Cash at bank and in hand54/58€25k
Equity and liabilities
Total equity and liabilities10/49€1.13M
Equity10/15€44k
Contributions10/11€10k
Reserves13€34k
Distributable reserves133€34k
Amounts payable17/49€1.08M
Amounts payable after more than one year17€970k
Financial debts170/4€970k
Amounts payable within one year42/48€111k
Current portion of amounts payable after more than one year42€59k
Trade debts44€4k
Suppliers440/4€4k
Taxes, remuneration and social security45€23k
Taxes450/3€21k
Remuneration and social security454/9€2k
Other amounts payable47/48€26k
Accrued charges and deferred income492/3€404
Income statement
Code2025
Gross operating margin9900€81k
Operating profit (loss)9901€81k
Financial charges65/66B€36k
Recurring financial charges65€36k
Profit (loss) for the period before taxes9903€45k
Income taxes67/77€10k
Profit (loss) for the period9904€35k
Profit (loss) for the period to be appropriated9905€35k
Appropriation of the result
Profit (loss) to be appropriated9906€35k
Transfer to equity691/2€34k
To other reserves6921€34k
Profit to be distributed694/7€833
Return on contributions (dividend)694€833
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
29-06
State Gazette act
Incorporation · Founder
Founding capital · Bank account
State Gazette actNBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Verviers · 1 establishment unit since 2025
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Jules Spinhayer 424800 VerviersGround area
240 m²
Building footprint
56 m²
Volume, LiDAR
570 m³
Parcel 63079D0415/00S023, Wallonia · tallest building 11.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
CHASPIERRE HOLDING
since 20252.369.665.953
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63079D0415/00S023 | Wallonia | 240 m² | 1 · 56 m² | 11.5 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Ownership & control
1 board mandateBoard mandates of this companythis company sits on their board1
1 location
Similar companies · same sector, comparable size
TAM PHARMA
BE 0778.614.248
Sint-Jans-Molenbeek · Eq €43,818
Pharma Poperinge
BE 0756.924.553
Gent · Eq €43,854
LINDA PHARMA
BE 1025.098.275
Etterbeek · Eq €43,688
Pharm@dvice
BE 0829.109.874
Fexhe-le-Haut-Clocher · Eq €44,047
JDS Pharma
BE 1012.963.476
La Louvière · Eq €43,542
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 2,582 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded24-01-2025
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.